Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cellsSherif S. Morgan(University of Arizona Cancer Center), Lee D. Cranmer(University of Washington)BMC Research NotesJanuary 1, 201410.1186/1756-0500-7-812Cited by 17SaveCiteExport RISWatch citationsRelated PapersPerformance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients|BMC Cancer|2018|142